MEDIANALtd Valuation
Is A041920 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of A041920 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: A041920 (₩6700) wird unter unserer Schätzung des Fair Value (₩29693.71) gehandelt.
Deutlich unter dem Marktwert: A041920 wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A041920?
Other financial metrics that can be useful for relative valuation.
What is A041920's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₩128.81b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1x |
Enterprise Value/EBITDA | 6.7x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does A041920's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 12.5x | ||
A035610 Solborn | 3.2x | n/a | ₩123.7b |
A228850 Rayence | 7.2x | 7.2% | ₩141.6b |
A208370 SELVAS Healthcare | 27.4x | n/a | ₩141.9b |
A263690 DRGEM | 12x | n/a | ₩110.4b |
A041920 MEDIANALtd | 14.5x | n/a | ₩128.8b |
Price-To-Earnings gegen Gleichaltrige: A041920 ist auf der Grundlage des Price-To-Earnings Verhältnisses (14.2x) im Vergleich zum Durchschnitt der Vergleichsgruppe (13.7x) teuer.
Price to Earnings Ratio vs Industry
How does A041920's PE Ratio compare vs other companies in the KR Medical Equipment Industry?
Price-To-Earnings gegen Industrie: A041920 ist aufgrund seines Price-To-Earnings Verhältnisses (14.6x) im Vergleich zum KR Medical Equipment Branchendurchschnitt (16.1x) ein guter Wert.
Price to Earnings Ratio vs Fair Ratio
What is A041920's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 14.5x |
Fair PE Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Earnings Fair Ratio von A041920 für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.